Category

News
A global panel of experts convened by the International Myeloma Society has published consensus guidelines and recommendations for the prevention of infection in multiple myeloma, which remains the leading cause of morbidity and mortality in patients despite advances in treatment response.
Continue Reading
The Medicine Gap was created by a group of concerned New Zealanders who believe the Government must address this country’s escalating medicines crisis. It aims to provide a collective voice to the thousands of sick and vulnerable New Zealanders who can’t afford life-transforming or life-saving drugs to live. This week they covered Multiple Myeloma with two voices....
Continue Reading
On Demand Webinar by thelimbic live From the comfort of your own desk (or armchair) … watch the latest event in Myeloma Australia’s MAGIC myeloma case series in your own time. Dr Nicholas Weber leads an expert panel and live audience as they problem solve VRD refractoriness, mobilisation failure and lenalidomide maintenance in 3 challenging...
Continue Reading
Wellington End of Year Function Date for 2022 to be advised. It is a requirement to be double vaccinated to attend this event.
Continue Reading
By Selina Wellbelove – 15 Nov 2021 Vaccinated patients with blood cancers experiencing breakthrough COVID-19 infections remain at high risk for severe or critical disease and death, new research shows. Furthermore, it was found that patients with lymphomas were more at risk than those with other haematological malignancies. The study, led by Dr Livio Pagano,...
Continue Reading
A study showing fatigue is common and enduring in non-Hodgkin lymphoma (NHL) survivors has highlighted the need for more proactive screening and management in blood cancer patients, an Australian occupational therapist says. The US study, which assessed fatigue’s prevalence and persistence in 555 NHL survivors, found it occurred in more than a quarter of patients at...
Continue Reading
Nichola Oakenfull is partially vaccinated against Covid-19, but she’s still scared. The Wellington woman was diagnosed with multiple myeloma (a type of blood cancer) during alert level 3 last year – a diagnosis that may reduce the efficacy of the Pfizer vaccine. “It is very scary because I’m doing as much as I can to try and keep myself safe, but you are relying...
Continue Reading
This Phase I trial is now open at Middlemore Hospital in Auckland for t (11,14 ) RRMM patients.
Continue Reading
This article originally published on The Limbic Most parents of children undergoing active cancer treatment at the RCH Children’s Cancer Centre, Melbourne last year reported no change to their child’s care due to COVID-19. An online survey of more than 100 parents in October-November 2020 found 69% reported no change to their child’s treatment plan...
Continue Reading
Pomalidomide (Pomalyst) in combination with bortezomib and dexamethasone (PVd) will be reimbursed on the PBS from 1 October for patients with relapsed or refractory  multiple myeloma who have received at least one prior treatment regimen including lenalidomide. According to distributor Bristol Myers Squibb, the thalidomide analogue was approved based on findings from the OPTIMISMM trial...
Continue Reading
1 2 3 4 5 36

Floor 7, 90 The Terrace
Wellington Central
New Zealand